Cognitive deterioration in adult epilepsy: Does accelerated cognitive ageing exist?

Neurosci Biobehav Rev

Department of Behavioral Sciences, Department of Neurology, Department of Research and Development, Epilepsy Centre Kempenhaeghe, P.O. Box 61, 5590 AB Heeze, The Netherlands; Department of Electrical Engineering, Department of Biomedical Engineering, University of Technology, P.O. Box 513, 5600 MB Eindhoven, The Netherlands; Laboratory for Clinical and Experimental Neurophysiology, Neurobiology and Neuropsychology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium; Department of Neurology, Department of Clinical Neurophysiology, Maastricht University Medical Center, P.O. Box 616, 6200 MD Maastricht, The Netherlands.

Published: May 2016

A long-standing concern has been whether epilepsy contributes to cognitive decline or so-called 'epileptic dementia'. Although global cognitive decline is generally reported in the context of chronic refractory epilepsy, it is largely unknown what percentage of patients is at risk for decline. This review is focused on the identification of risk factors and characterization of aberrant cognitive trajectories in epilepsy. Evidence is found that the cognitive trajectory of patients with epilepsy over time differs from processes of cognitive ageing in healthy people, especially in adulthood-onset epilepsy. Cognitive deterioration in these patients seems to develop in a 'second hit model' and occurs when epilepsy hits on a brain that is already vulnerable or vice versa when comorbid problems develop in a person with epilepsy. Processes of ageing may be accelerated due to loss of brain plasticity and cognitive reserve capacity for which we coin the term 'accelerated cognitive ageing'. We believe that the concept of accelerated cognitive ageing can be helpful in providing a framework understanding global cognitive deterioration in epilepsy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neubiorev.2016.02.004DOI Listing

Publication Analysis

Top Keywords

cognitive
12
cognitive deterioration
12
cognitive ageing
12
epilepsy
9
accelerated cognitive
8
cognitive decline
8
global cognitive
8
deterioration adult
4
adult epilepsy
4
epilepsy accelerated
4

Similar Publications

l-theanine: From tea leaf to trending supplement - does the science match the hype for brain health and relaxation?

Nutr Res

January 2025

Department of Molecular Medicine, University of Padova, Padova, Italy; IMDEA-Food, Madrid, Spain. Electronic address:

l-Theanine is a unique non-protein amino acid found abundantly in tea leaves. Interest in its potential use as a dietary supplement has surged recently, especially claims related to promoting relaxation and cognitive enhancement. This review surveys the chemistry, metabolism, and purported biological activities of l-theanine.

View Article and Find Full Text PDF

Objective: Epilepsy is a common neurological disease affecting nearly 1% of the global population, and temporal lobe epilepsy (TLE) is the most common type. Patients experience recurrent seizures and chronic cognitive deficits that can impact their quality of life, ability to work, and independence. These cognitive deficits often extend beyond the temporal lobe and are not well understood.

View Article and Find Full Text PDF

Background: There is potential for digital mental health interventions to provide affordable, efficient, and scalable support to individuals. Digital interventions, including cognitive behavioral therapy, stress management, and mindfulness programs, have shown promise when applied in workplace settings.

Objective: The aim of this study is to conduct an umbrella review of systematic reviews in order to critically evaluate, synthesize, and summarize evidence of various digital mental health interventions available within a workplace setting.

View Article and Find Full Text PDF

Background: Digital technologies for type 2 diabetes mellitus (T2DM) care hold great potential to improve patients' health in the long term. Only a subset of telemedicine offerings are digital interventions that meet the criteria for prescribable digitale Gesundheitsanwendung (digital health apps; DiGAs) in Germany. Digital treatments further provide vast amounts of patient data that are important to generate evidence.

View Article and Find Full Text PDF

Background: Cognition is a research priority for people living with chronic kidney disease (CKD), but identification of critical research questions is lacking. This study aimed to determine which cognition-related research questions are most important to CKD stakeholders.

Methods: A modified Delphi technique with 3 survey rounds was used.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!